TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...

The oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 revealed a manageable safety profile in relapsed ...

Organ Preservation Market Organ Preservation Market grows with rising transplants, advanced perfusion tech, and demand for solutions that b ...

Tough times don’t last, but tough men do. And it is safe to say that Ben Askren is living proof The post ‘Healing’ Ben Askren Readmitted To Hospital After Double Lung Transplant: “Not All Sunshine And ...

With limited treatment options and potential for admission to the intensive care unit, researchers of a new paper highlighted ...

GEO-MVA received favorable European regulatory guidance supporting streamlined development pathway GEO-CM04S1 demonstrates ...

Ben Askren, the 41-year-old former UFC fighter and Olympic wrestler, has returned home after a 59-day hospital stay. He ...

While chemotherapy remains a cornerstone of lung cancer treatment, it often weakens the immune system it relies on for ...

It was a Sunday morning at 11.46 in the middle of a lunchtime gig when Brisbane country singer Seleen McAlister’s phone rang ...

This approval for XPOVIO® in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with multiple myeloma (MM) who have ...